Related Experiment Video
Updated: May 3, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
AutoShim: empirically corrected scoring functions for quantitative docking with a crystal structure and IC50 training
Eric J Martin1, David C Sullivan
1Department of Computer Aided Drug Discovery, Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, USA. eric.martin@novartis.com
AutoShim improves drug discovery by creating tailored scoring functions for protein targets using pharmacophore "shims." This method enhances binding affinity predictions, aiding in the identification of effective drug candidates.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Developing accurate scoring functions for high-throughput docking is challenging.
- Existing methods struggle to correlate with measured binding affinity.
Purpose of the Study:
- To present AutoShim, a novel method for improving binding affinity predictions in drug discovery.
- To adapt general scoring functions for specific protein targets using pharmacophore shims.
Main Methods:
- AutoShim utilizes the Magnet program to add pharmacophore-like shims to protein binding sites.
- Partial least-squares (PLS) regression weights the shims to optimize scoring functions against IC50 data.
- An iterative procedure refines poses and parameters, ensuring robust model convergence.
Main Results:
- AutoShim significantly improves affinity prediction accuracy for held-out compounds.
- The method demonstrates reproducible convergence in 2-4 iterations, avoiding overtraining.
- Simpler pharmacophore shims provide reasonable predictions and clear molecular interaction insights.
Conclusions:
- AutoShim offers a practical and effective approach to enhance binding affinity prediction in drug discovery.
- The method provides reproducible and interpretable results, aiding in the design of new drug compounds.
- This automated procedure requires a training set but adds minimal computational overhead.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025